In an American Arbitration Association (AAA) dispute over early-stage drug candidates in a development agreement between two biopharmaceutical companies, CRA consultants quantified damages associated with the alleged breach of the agreement. Dr. Gregory K. Bell submitted an expert report quantifying actual loss damages and unjust enrichment and provided deposition and hearing testimony to support the damages assessment.
Trade Secret Protection: A Global Guide
The law of trade secrets is one of the most important and fastest developing areas of intellectual property, but is by far the least harmonized...